A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder
Principal Investigator
M. Michaelson, MD PhD
Status
Terminated
Date of Study Termination
May 20 2022
Disease Site
Genitourinary [GU]
Bladder
Phase
I/II
Developmental Therapeutics
No
Primary Objective
Patient Population
-
Target Accrual
88
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.